GGrantIndex
Sort

1,049,261 grants matching t cell

The Vanderbilt Molecular Target Discovery and Development Center

$2,536,958
Lawrence J Marnett · Vanderbilt University · RC2 · FY2010 · CA

Experimental Therapy for Brain Tumors

$2,536,844
John H Sampson · Duke University · P01 · FY2020 · CA

GENERAL CLINICAL RESEARCH CENTER M01 RR12248

$2,536,608
Allen M. Spiegel · Albert Einstein College Of Medicine · M01 · FY2007 · RR

Assessing desiccation tolerance's impact on Aedes aegypti midgut infection

$2,536,503
Laura B Dickson · University Of Texas Med Br Galveston · R01 · FY2025 · AI

Collaboratory for atlasing cell type anatomy in the female and male mouse brain

$2,536,453
Pavel Osten · Cold Spring Harbor Laboratory · U01 · FY2017 · MH

Genetic Analysis of Resistance to Viral Infection

$2,536,276
Bruce A Beutler · Scripps Research Institute, The · P01 · FY2009 · AI

Nuclear Architecture and Disease

$2,536,118
Thomas A Misteli · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome Function

$2,536,038
John T Lis · Cornell University · RM1 · FY2023 · GM

Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome Function

$2,536,038
John T Lis · Cornell University · RM1 · FY2025 · GM

Structure, Function, and Dynamics of Macro-molecular Complexes that Execute and Regulate Genome Function

$2,536,038
John T Lis · Cornell University · RM1 · FY2024 · GM

Functional Genetics of COPD

$2,536,013
Edwin K Silverman · Brigham And Women'S Hospital · P01 · FY2012 · HL

Biogenesis, Function and Turnover of Noncoding RNAs

$2,536,004
Sandra Wolin · Division Of Basic Sciences - Nci · ZIA · FY2024 · CA

PHARMACOGENETICS OF ANTICANCER AGENTS RESEARCH GROUP

$2,535,904
University Of Chicago · U01 · FY2000 · GM

Research Services Section (RSS)

$2,535,862
Samuel Michael · National Center For Advancing Translational Sciences · ZIC · FY2017 · TR

Neuroactive steroids as novel psychiatric treatments: mechanistic studies

$2,535,717
Steven J Mennerick · Washington University · P50 · FY2021 · MH

MOLECULAR & CELLULAR MECHANISMS IN TRANSFUSION MEDICINE

$2,535,513
Peter J Newman · Versiti Wisconsin, Inc. · P01 · FY2010 · HL

Clinical Epidemiology and Pathogenesis of Asymptomatic HSV

$2,535,398
Anna Wald · University Of Washington · P01 · FY2017 · AI

The UPMC Sexually Transmitted Infections Cooperative Research Center

$2,535,320
Toni Darville · University Of Pittsburgh At Pittsburgh · U19 · FY2010 · AI

NHGRI/DIR Scientific Computing

$2,535,165
Andreas Baxevanis · National Human Genome Research Institute · ZIH · FY2018 · HG

Selection of Novel Therapies to Ablate Chemoresistant Myeloid Leukemia Stem Cell

$2,535,000
Monica L Guzman · Weill Medical Coll Of Cornell Univ · DP2 · FY2010 · OD

Mapping Structure-Activity Relationships of Chemical Inhibitors via Genome-Editing

$2,535,000
Brian Liau · Harvard University · DP2 · FY2019 · GM

Single-cell epigenomic and cellular plasticity

$2,535,000
Jason Daniel Buenrostro · Harvard University · DP2 · FY2019 · HL

The discovery of microRNAs that predict chemotherapeutic responsiveness of cancer

$2,535,000
Sohail F. Tavazoie · Rockefeller University · DP2 · FY2009 · OD

Contribution of bone marrow cells to tissue regeneration

$2,534,982
Eva M. Mezey · National Institute Of Dental & Craniofacial Research · ZIA · FY2017 · DE

MSKCC CENTER FOR IN VIVO MOLECULAR IMAGING IN CANCER

$2,534,953
Sloan-Kettering Institute For Cancer Res · P50 · FY2004 · CA